Applied therapeutics to present at the 43rd annual meeting of the society for inherited metabolic disorders

New york, april 04, 2022 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced poster presentations at the 2022 43rd annual meeting of the society for inherited metabolic disorders, april 10 - 13, 2022 in orlando, florida.
APLT Ratings Summary
APLT Quant Ranking